National Heart, Lung, and Blood Institute; Notice of Closed Meeting, 70520 [06-9525]

Download as PDF 70520 Federal Register / Vol. 71, No. 233 / Tuesday, December 5, 2006 / Notices current certification process with the exception of the requirement ‘‘for nurse/ pharmacist certification through AAPCC.’’ From the comments received, there is consensus support for the AAPCC certification program. The guidelines by which the Secretary shall approve a professional organization and/or State government as having standards for certification will be that any certification program must meet or exceed current certification standards being used by AAPCC to certify PCCs. Send comments to Maxine Jones, HRSA, HSB, Division of Healthcare Preparedness, Healthcare Systems Bureau, Room 13–103, 5600 Fishers Lane, Rockville, MD 20857. Comments should be received within 60 days of this notice. Dated: November 28, 2006. Elizabeth M. Duke, Administrator. [FR Doc. E6–20564 Filed 12–4–06; 8:45 am] BILLING CODE 4165–15–P National Institutes of Health Second Annual Philip S. Chen, Jr. Distinguished Lecture on Innovation and Technology Transfer National Institutes of Health, Public Health Service, HHS. ACTION: Notice. AGENCY: SUMMARY: The Office of the Director, NIH, invites you to the second annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer. DATES: Friday, January 26, 2007, at 1 p.m. NIH campus, 9000 Rockville Pike, Bethesda MD, NIH Clinical Center (Building 10), Lipsett Auditorium. ADDRESSES: For additional information, sign language interpretation or accommodation for disabilities, please contact Colleen Crone at 301–496–1921 or cronec@od.nih.gov. FOR FURTHER INFORMATION CONTACT: Dr. Douglas R. Lowy will present ‘‘The Science, Technology and Promise of Preventive HPV Vaccines.’’ Dr. Lowy is Chief of the Basic Research Laboratory and the Laboratory of Cellular Oncology at the NCI Center for Cancer Research, where he also serves as deputy director. With colleagues at NIH, he developed ycherry on PROD1PC64 with NOTICES VerDate Aug<31>2005 15:14 Dec 04, 2006 Jkt 211001 Dated: November 27, 2006. Bonny Harbinger, Deputy Director, Office of Technology Transfer, National Institutes of Health. [FR Doc. E6–20577 Filed 12–4–06; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES SUPPLEMENTARY INFORMATION: the original technology on which the Merck HPV vaccine, Gardasil, is based. This annual series honors Dr. Philip S. Chen, Jr. for his almost 50 years of service to the National Institutes of Health. Dr. Chen established NIH’s Office of Technology Transfer in 1986 to implement the Federal Technology Transfer Act. The inventions in the Office of Technology Transfer’s intellectual property portfolio are crucial in advancing the NIH mission— making important discoveries that improve health and save lives. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Research in Severe Asthma. Date: December 12, 2006. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Valerie L. Prenger, PhD, Health Scientist Administrator, Division of Extramural Affairs, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, MSC 7924, Room 7214, Bethesda, MD 20892–7924, (301) 435–0270. prengerv@nhlbi.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for PO 00000 Frm 00020 Fmt 4703 Sfmt 4703 Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: November 28, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–9525 Filed 12–4–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Development of State-of-the-Art Mechanisms for Epidemiological Research. Date: December 6, 2006. Time: 1:30 p.m. to 3 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Eric Zatman, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892– 8401, (301) 435–1438. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Develop a Real-Time fMRI Feedback System that Allows Drug Abusers to Control Cravings and Urges and/or Increase Their Self-Control of Their Drug Taking. Date: December 20, 2006. Time: 10 a.m. to 12 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). E:\FR\FM\05DEN1.SGM 05DEN1

Agencies

[Federal Register Volume 71, Number 233 (Tuesday, December 5, 2006)]
[Notices]
[Page 70520]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-9525]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel, Research in Severe Asthma.
    Date: December 12, 2006.
    Time: 2 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Valerie L. Prenger, PhD, Health Scientist 
Administrator, Division of Extramural Affairs, National Heart, Lung, 
and Blood Institute, 6701 Rockledge Drive, MSC 7924, Room 7214, 
Bethesda, MD 20892-7924, (301) 435-0270. prengerv@nhlbi.nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: November 28, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-9525 Filed 12-4-06; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.